Zhang Yanyan, Liu Yaokun, Zhang Bin, Yang Fan, Gong Yanjun, Zheng Bo, Huo Yong
Department of Cardiology, Peking University First Hospital, Beijing, 100034, China.
Perioper Med (Lond). 2024 Oct 14;13(1):103. doi: 10.1186/s13741-024-00462-z.
Simplified rapid hydration has been proven to be non-inferior to standard hydration in preventing contrast-associated acute kidney injury among chronic kidney disease patients undergoing coronary angiography. The current investigation aimed to further confirm the feasibility and safety of the newly proposed hydration method-simplified rapid hydration (SH) in each risk stratification by Mehran risk score (MRS). Eligible patients (n = 954) randomized to the SH group and standard hydration group were allocated into 2 groups based on MRS: low to moderate-risk and high to very high-risk groups. Primary endpoints were the incidence of contrast-associated acute kidney injury (CA-AKI) and acute heart failure (AHF) (SH vs standard hydration). Secondary endpoints included serum creatinine (Scr), blood urea nitrogen (BUN), cystatin-C (Cys-C), and C-reactive protein (CRP) at 24 h, 48 h, and 72 h after PCI procedure, and the incidence of major adverse cardiac events (MACE). MRS was associated with a higher incidence of CA-AKI (OR = 1.101, 95%CI 1.049-1.156, P < 0.001). In the low to moderate-risk and high to very-high-risk groups, the incidence of CA-AKI in the SH and standard hydration group was 3.3% versus 4.9% (P = 0.5342), 10% versus 12% (P = 0.6392), respectively. Meanwhile, there might be subtle differences in renal function indexes and inflammatory indicators between SH and the control group at different time points. The preventive effect of SH in CA-AKI was similar to standard hydration regardless of MRS-guided risk stratification.
在接受冠状动脉造影的慢性肾脏病患者中,简化快速水化已被证明在预防对比剂相关急性肾损伤方面不劣于标准水化。本研究旨在通过梅兰风险评分(MRS)进一步证实新提出的水化方法——简化快速水化(SH)在各风险分层中的可行性和安全性。将符合条件的患者(n = 954)随机分为SH组和标准水化组,并根据MRS分为两组:低至中度风险组和高至极高风险组。主要终点为对比剂相关急性肾损伤(CA-AKI)和急性心力衰竭(AHF)的发生率(SH组与标准水化组)。次要终点包括PCI术后24小时、48小时和72小时的血清肌酐(Scr)、血尿素氮(BUN)、胱抑素C(Cys-C)和C反应蛋白(CRP),以及主要不良心脏事件(MACE)的发生率。MRS与CA-AKI的较高发生率相关(OR = 1.101,95%CI 1.049 - 1.156,P < 0.001)。在低至中度风险组和高至极高风险组中,SH组和标准水化组的CA-AKI发生率分别为3.3%对4.9%(P = 0.5342)、10%对12%(P = 0.6392)。同时,SH组与对照组在不同时间点的肾功能指标和炎症指标可能存在细微差异。无论MRS指导的风险分层如何,SH在预防CA-AKI方面的效果与标准水化相似。